Are you up to date on the latest clinical trial data on antibody-drug conjugates (ADCs) in hormone receptor (HR)-positive advanced breast cancer? Credit available for this activity expires: 11/20/23 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998605?ecd=bdc_podcast_libsyn_mscpedu)
